Search by Drug Name or NDC

    NDC 71879-0001-01 Dexycu 517 ug/.005mL Details

    Dexycu 517 ug/.005mL

    Dexycu is a INTRAOCULAR INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by EyePoint Pharmaceuticals US, Inc. The primary component is DEXAMETHASONE.

    Product Information

    NDC 71879-0001
    Product ID 71879-001_cb8f6417-27b3-441b-81b8-6b3a1ee87365
    Associated GPIs 86300010001860
    GCN Sequence Number 078417
    GCN Sequence Number Description dexamethasone/PF VIAL 9 % INTRAOCULR
    HIC3 Q6P
    HIC3 Description EYE ANTI-INFLAMMATORY AGENTS
    GCN 44741
    HICL Sequence Number 044921
    HICL Sequence Number Description DEXAMETHASONE/PF
    Brand/Generic Brand
    Proprietary Name Dexycu
    Proprietary Name Suffix n/a
    Non-Proprietary Name dexamethasone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION
    Route INTRAOCULAR
    Active Ingredient Strength 517
    Active Ingredient Units ug/.005mL
    Substance Name DEXAMETHASONE
    Labeler Name EyePoint Pharmaceuticals US, Inc
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208912
    Listing Certified Through 2024-12-31

    Package

    NDC 71879-0001-01 (71879000101)

    NDC Package Code 71879-001-01
    Billing NDC 71879000101
    Package 1 VIAL, GLASS in 1 CARTON (71879-001-01) / .5 mL in 1 VIAL, GLASS
    Marketing Start Date 2018-05-22
    NDC Exclude Flag N
    Pricing Information N/A